SEARCH

SEARCH BY CITATION

References

  • 1
    Sisson DD, Thomas WP. Myocardial diseases. In: EttingerSJ, ed. Textbook of Veterinary Internal Medicine. Diseases of the Dog and Cat, 4th ed. Philadelphia, PA: WB Saunders; 1995:9951032.
  • 2
    Buchanan JW. Causes and prevalence of cardiovascular disease. In: KirkRW, BonaguraJD, eds. Current Veterinary Therapy XI. Philadelphia, PA: WB Saunders; 1992:647654.
  • 3
    Calvert CA, Meurs KM. CVT update: Doberman Pinscher occult cardiomyopathy. In: BonaguraJD, ed. Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:756760.
  • 4
    O'Grady MR, O'Sullivan ML. Dilated cardiomyopathy: An update. Vet Clin Small Anim 2004;34:11871207.
  • 5
    Wynne J, Braunwald E. The cardiomyopathies. In: ZipesDP, LibbyP, BonowRO, BraunwaldE, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed. Philadelphia, PA: WB Saunders; 2005:16591696.
  • 6
    Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 1998;213:15731577.
  • 7
    The BENCH (Benazepril hydrochloride in Canine Heart disease) Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardio 1999;1:718.
  • 8
    Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:17241729.
  • 9
    Koch J, Pedersen HD, Jensen AL, et al. Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res in Vet Sci 1995;59:172175.
  • 10
    Tidholm A, Haggstrom J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res 2001;62:961967.
  • 11
    O'Sullivan ML, O'Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:9299.
  • 12
    SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685691.
  • 13
    Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1e82.
  • 14
    Sidak Z. Rectangular confidence regions for the means of multivariate normal distributions. J Am Statitical Assoc 1967;62:626622.
  • 15
    Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248254.
  • 16
    Abdulla J, Barlera S, Latini R, et al. A systemic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction. Eur J Heart Fail 2007;9:129135.
  • 17
    Asselbergs FW, Van Gilst WH. Angiotensin converting enzyme inhibition in cardiovascular risk populations: A practical approach to identify the patient who will benefit most. Curr Opin Cardiol 2007;22:267272.
  • 18
    O'Grady MR, Minors S, O'Sullivan ML, et al. Effect of pimobendan on case fatality rate in Doberman Pinschers in congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med 2008;22:897904.
  • 19
    Fuentes VL, Corcoran B, French A, et al. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med 2002;16:255261.
  • 20
    Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:8088.
  • 21
    Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 2007;231:10611069.
  • 22
    Perry GJ, Wei C, Hakes GH, et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 2002;39:13741379.
  • 23
    Gaasch WH, Aurigemma GP. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol 2002;39:13801383.